Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Work In Process (2023 - 2024)

Historic Work In Process for Zevra Therapeutics (ZVRA) over the last 2 years, with Q3 2024 value amounting to $3.1 million.

  • Zevra Therapeutics' Work In Process changed N/A to $3.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2023, which is N/A changed from last year.
  • As of Q3 2024, Zevra Therapeutics' Work In Process stood at $3.1 million.
  • In the past 5 years, Zevra Therapeutics' Work In Process ranged from a high of $3.3 million in Q2 2024 and a low of $1.9 million during Q4 2023